-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
-
Summary
-
Transcode Therapeutics, Inc. quarterly/annual Operating Lease, Payments history and change rate from Q1 2022 to Q3 2025.
- Transcode Therapeutics, Inc. Operating Lease, Payments for the quarter ending 30 Sep 2025 was $11.3K, a 89.8% decline year-over-year.
- Transcode Therapeutics, Inc. Operating Lease, Payments for the twelve months ending 30 Sep 2025 was $233K, a 33.2% decline year-over-year.
- Transcode Therapeutics, Inc. annual Operating Lease, Payments for 2024 was $412K, a 28.4% decline from 2023.
- Transcode Therapeutics, Inc. annual Operating Lease, Payments for 2023 was $575K, a 74.5% increase from 2022.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Change (%)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Change (%)